Your session is about to expire
← Back to Search
Dental Health Assessment for Esophageal Cancer
N/A
Recruiting
Led By Steven Maron, MD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial seeks to understand why tooth enamel wears away in people with esophagogastric cancer & how often it occurs.
Who is the study for?
This study is for adults over 18 with esophagogastric cancer who can understand English or have translation services. They should be able to complete a survey and allow photos of their teeth, but those without teeth or major dental work on molars that affects enamel assessment cannot join.
What is being tested?
The study aims to understand tooth enamel loss in people with various cancers including esophagogastric cancer. Participants will provide saliva samples, answer surveys about their oral health, and have pictures taken of their teeth using an intra-oral camera.
What are the potential side effects?
Since this trial involves non-invasive procedures like surveys and taking pictures inside the mouth, there are no significant side effects expected from participating in this research.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
The incidence of dental erosions
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Group I: Patients diagnosed with esophagogastric cancerExperimental Treatment3 Interventions
Patients have completed the intervention once completing the survey, undergoing dental imaging and future patients will also provide an optional saliva sample.
Group II: Patients diagnosed with colorectal, pancreatic, breast, head and neck, or non-small cell lung cancerExperimental Treatment2 Interventions
Patients undergo consenting and dental imaging during their routine visits at MSK.
Group III: Healthy volunteers who have not been diagnosed with cancerExperimental Treatment2 Interventions
Healthy controls will be defined as those without a known or suspected invasive cancer history and excluding those undergoing a procedure for symptomatic reflux.
Find a Location
Who is running the clinical trial?
Memorial Sloan Kettering Cancer CenterLead Sponsor
1,979 Previous Clinical Trials
599,538 Total Patients Enrolled
Steven Maron, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
1 Previous Clinical Trials
25 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I have never had cancer (other than skin cancer) and am not being evaluated for reflux.I don't have molars or have had significant dental work on them.I have a history of specific cancers or I am a healthy volunteer.
Research Study Groups:
This trial has the following groups:- Group 1: Patients diagnosed with esophagogastric cancer
- Group 2: Patients diagnosed with colorectal, pancreatic, breast, head and neck, or non-small cell lung cancer
- Group 3: Healthy volunteers who have not been diagnosed with cancer
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.